Clinical outcomes of COVID-19 in patients with multiple sclerosis treated with ocrelizumab in the pre- and post-SARS-CoV-2 vaccination periods: Insights from Israel
Janick Weberpals, Spyros Roumpanis, Yael Barer, Sharon Ehrlich, Nikki Jessop, Rosetta Pedotti, Adi Vaknin-Dembinsky, Livnat Brill, Gabriel Chodick, Erwan Muros Le Rouzic
Research output: Contribution to journal › Letter › peer-review
Fingerprint
Dive into the research topics of 'Clinical outcomes of COVID-19 in patients with multiple sclerosis treated with ocrelizumab in the pre- and post-SARS-CoV-2 vaccination periods: Insights from Israel'. Together they form a unique fingerprint.